Herpes zoster
☆ AI Dermatology — Free Service
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Herpes zoster: tasy eo amin'ny tendany sy ny soroka
relevance score : -100.0%
ReferencesNy shingles, vokatry ny famelomana indray ny viriosy varicella zoster tompon'andraikitra amin'ny pox, dia misy fiantraikany amin'ny olona 1 tapitrisa isan-taona any Etazonia, miaraka amin'ny risika 30% mandritra ny androm-piainany. Ireo izay manana rafi‑kery fanefitra malemy dia mora voan'ny shingles, ary matetika manomboka amin'ny soritr'aretina toy ny tsy fahampian-tsakafo, aretin'andoha, ary tazo malemy, arahin'ny fahatsapana tsy mahazatra amin'ny hoditra mandritra ny andro vitsivitsy alohan'ny fisehoan'ny maimaika. Ity maimaika ity, matetika miseho amin'ny faritra manokana amin'ny vatana, dia mandroso avy amin'ny blister mazava ho amin'ny fery mipetaka mandritra ny herinandro ka hatramin'ny folo andro. Tena ilaina ny fitsaboana haingana amin'ny fanafody antiviral (acyclovir, valacyclovir, famciclovir) ao anatin'ny 72 ora aorian'ny fisehoan'ny maimaika. Ny neuralgia postherpetic, fanaintainana maharitra eo amin'ny faritra voakasika, dia miseho amin'ny marary iray amin'ny dimy ary mitaky fitsaboana mitohy amin'ny fanafody toy ny gabapentin, pregabalin, na antidepressants sasany, ary koa fanafody topical toy ny lidocaine na capsaicin. Ny vaksiny amin'ny viriosy varicella zoster dia atolotra ho an'ny olon‑dehibe 50 taona sy miakatra mba hampihenana ny mety ho voan'ny shingles.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Herpes zoster dia miseho matetika kokoa amin'ny olona 50 taona na miakatra, ireo manana hery fiarovana malemy ary ireo izay mandray fanafody immunosuppressant. Ny viriosy varicella-zoster, ilay viriosy mahatonga ny pox, no mahatonga azy io. Ny soritr'aretina toy ny tazo, fanaintainana ary mangidihidy dia matetika mialoha ny fisehoan'ny maimaika. Ny fahasarotana mahazatra indrindra dia ny neuralgia post-herpetic, izay fanaintainan'ny nerveuse maharitra aorian'ny fivoahan'ny maimaika. Ny antony mety hampidi-doza sy ny fahasarotana mifandray amin'ny herpes zoster dia miovaova arakaraka ny taona, ny toe-pahasalamana amin'ny hery fiarovana, ary ny fotoana nanombohana ny fitsaboana. Ny vaksiny ho an'ny olona 60 taona na miakatra dia hita fa mampihena be ny fisian'ny herpes zoster sy ny neuralgia post-herpetic. Ny fanombohana fanafody antiviral sy fanamaivanana fanaintainana ao anatin'ny 72 ora manomboka ny maimaika dia mety hampihena ny fahasarotana sy ny soritr'aretin'ny herpes zoster ary ny neuralgia post-herpetic.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Ny fitsapana klinika alohan'ny fankatoavana dia manondro fa ny vaksiny zoster velona dia miasa manodidina ny 50% ka hatramin'ny 70%, raha ny vaksiny recombinant kosa dia miasa tsara kokoa, manomboka amin'ny 90% ka hatramin'ny 97%. Amin'ny fanadihadiana tena izy dia manohana ny valin'ny fitsapana izy ireo, mampiseho fa ny vaksiny velona dia mahomby 46%, raha ny recombinant kosa dia manodidina ny 85%.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
Ny pox, antsoina koa hoe varicella, dia vokatry ny otrikaretina voalohany amin'ny viriosy, matetika miseho mandritra ny fahazazana na fahatanorana. Rehefa sitrana ny nendra, dia mety hijanona tsy mavitrika (matory) ao amin'ny sela nerveo mandritra ny taona na am-polony taona maro ny viriosy, ary mety hiseho indray. Ny Herpes zoster dia vokatry ny fiverenan'ny viriosy varicella matory. Avy eo, mandeha amin'ny nerveo mankany amin'ny faritra hoditra izy, ka miteraka blister. Mandritra ny fipoahan'ny herpes zoster, ny viriosy varicella hita ao amin'ny blister dia mety hiteraka pox amin'ny olona mbola tsy voan'ny chickenpox.
Anisan'ny antony mety hahatonga ny viriosy matory hiverina ny fahanterana, ny hery fiarovana malemy, ary ny nendra voan'ny varicella alohan'ny faha‑18 volana. Ny viriosy varicella‑zoster dia tsy mitovy amin'ny viriosy herpes simplex, na dia ao anatin'ny fianakaviana iray aza ny herpes.
Ny vaksinin'ny herpes zoster dia mampihena 50%–90% ny mety hisian'ny aretina. Izy io koa dia mampihena ny tahan'ny postherpetic neuralgia (PHN) ary manamaivana ny hamafin'ny soritr'aretina raha sendra mitranga. Raha misy soritr'aretina, ny fanafody antiviral toy ny aciclovir dia afaka mampihena ny hamafin'ny aretina sy ny faharetany raha manomboka ao anatin'ny 72 ora aorian'ny fisehoan'ny maimaika.
○ Fitsaboana
Raha miparitaka haingana ny fery, dia jereo haingana ny dokotera mba hahazoana fitsaboana antiviral.
Samy ilaina ny fanafody antiviral sy ny fanafody neuralgia. Tokony hiala sasatra ianao ary tsy hisotro toaka intsony.
#Acyclovir
#Fancyclovir
#Valacyclovir
#Gabapentin
#Pregabalin